Evidence map›Paper›PMID 34544438›Full record

ArticleMalaria journal2021

The clinical-epidemiological profile of malaria patients from Southern Venezuela, a critical hotspot in Latin America.

David A Forero-Peña, Fhabián S Carrión-Nessi, Melynar Chavero, Ángel Gamardo, Luisamy Figuera, Natasha A Camejo-Ávila, María V Marcano, Mariana Hidalgo, Cariagne J Arenas-Leal, Leopoldo Villegas and 4 more

Abstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David A Forero-PeñaBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela. vacter.cv@gmail.com.
Fhabián S Carrión-NessiBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
Melynar ChaveroBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
Ángel GamardoBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
Luisamy FigueraBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
Natasha A Camejo-ÁvilaBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
María V MarcanoBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
Mariana HidalgoVenezuelan Institute of Scientific Research (IVIC), Miranda, Venezuela.
Cariagne J Arenas-LealBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.
Leopoldo VillegasCivil Association of Social Impact (ASOCIS), Tumeremo, Venezuela.
María E GrilletVector and Parasite Biology Laboratory, Tropical Ecology and Zoology Institute, Faculty of Sciences, Central University of Venezuela, Caracas, Venezuela.
M Andreína PachecoBiology Department/Institute of Genomics and Evolutionary Medicine (iGEM), Temple University, Philadelphia, PA, 19122-1801, USA.
Marisol Sandoval-de MoraDepartment of Internal Medicine, "Ruiz Y Páez" University Hospital Complex, Ciudad Bolivar, Venezuela.
Ananías A EscalanteBiology Department/Institute of Genomics and Evolutionary Medicine (iGEM), Temple University, Philadelphia, PA, 19122-1801, USA. ananias.escalante@temple.edu.ORCID http://orcid.org/0000-0002-1532-3430

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI GAZZINELLI, RICARDO TOSTES · 2010 to 2023
$20.1M
NIAID NIH HHS U19 AI089681
6 · The paper itself

Abstract

backgroundVenezuela accounted for 55% of the cases and 73% of the malaria deaths in the Americas in 2019. Bolivar state, in the southeast, contributes > 60% of the country's Plasmodium vivax and Plasmodium falciparum cases every year. This study describes the clinical-epidemiological characteristics of clinical malaria patients in this high-transmission area.

methodsA prospective study was conducted on patients seeking medical attention in three medical centres in the state capital, Ciudad Bolivar, between June and October 2018. Malaria diagnosis was carried out using microscopy following national standards. Malaria-positive patients were examined for clinical symptoms, and haematological tests were performed at the time of diagnosis. Patients were followed up by telephone to evaluate malaria recurrences.

resultsOut of 287 patients, 200 (69.7%) were positive for P. vivax, 69 (24%) for P. falciparum, and 18 (6.3%) had mixed (P. vivax/P. falciparum) infections. Patients' median age was 33 years (IQR 20), 168 (69%) were men, and 40% practiced gold mining as the main occupation. Fever (96.5%), chills (91.3%), and headaches (90.6%) were the most frequent symptoms. At least one symptom associated with severe malaria was observed in 69 out of 161 patients with complete clinical evaluation (42.9%). Plasmodium vivax infections were found in 42 out of 69 (60.9%) severe cases; by contrast, P. falciparum and mixed malaria caused 34.8% (24/69) and 4.4% (3/69) of infections, respectively. Two patients died of cerebral malaria. Mean hemoglobin was lower in the patients infected with P. falciparum than those infected with P. vivax. Regardless of the parasite causing the infection, patients presented high levels of total bilirubin, aminotransferases (AST, ALT), and lactate dehydrogenase (LDH). Out of the 142 patients followed up by phone for three months (49.5% of the 287 patients), 35 (24.7%) reported recurrences.

conclusionsThe high malaria prevalence among young male adults practicing gold mining suggests that this occupation is a significant risk factor. The unexpected high prevalence of P. vivax patients with at least one criteria of severe clinical disease is a matter of concern. Whether it is the result of a lack of timely diagnosis and effective treatment should be explored.

Indexed as

AdolescentAdultAgedFemaleHumansMalaria, FalciparumMalaria, VivaxMaleMiddle AgedMiningOccupational DiseasesPlasmodium falciparumPlasmodium vivaxPrevalenceRisk FactorsVenezuelaCerebral malariaPlasmodium falciparumPlasmodium vivaxSevere malaria

Identifiers

PMID34544438
PMCPMC8453994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.